All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals , whose medicines are part of the second round of ...

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Economists around the world expect muted U.S. economic growth in the coming quarters, and some indicators have shown an increased likelihood of a 2025 recession in recent weeks. It may become ...

Incorporating dynamic pricing into cost-effectiveness analysis could offer significant benefits for equity in health care.

The one-year increase was the second highest since the state established its benchmark to rein in expenditures in 2013.

In 2025, seniors will pay less for 64 medications if they get them through Medicare Part B, which covers outpatient care, ...

Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, ...

Today, Benzinga 's options scanner spotted 32 uncommon options trades for Biogen. This isn't normal. The overall sentiment of these big-money traders is split between 37% bullish and 31%, bearish. Out ...

The following offers perspectives from CDMOs and CROs on today’s oral solid dosage trends across drug development, ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

LOS ANGELES -- A little-known Chinese company has made a drug that beats the ... unexpected innovation at an unbelievable price. But this disruptive trend is not confined to Big Tech: it has ...